Evidence map›Paper›PMID 30154315›Full record

ReviewPharmaceutics2018

Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.

Silvia Franzé, Francesca Selmin, Elena Samaritani, Paola Minghetti, Francesco Cilurzo

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it, 221 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Silvia FranzéDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milano 20133, Italy. silvia.franze@unimi.it.
Francesca SelminDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milano 20133, Italy. francesca.selmin@unimi.it.ORCID 0000-0002-3680-6124
Elena SamaritaniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milano 20133, Italy. elena.samaritani@studenti.unimi.it.
Paola MinghettiDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milano 20133, Italy. paola.minghetti@unimi.it.
Francesco CilurzoDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G. Colombo 71, Milano 20133, Italy. francesco.cilurzo@unimi.it.ORCID 0000-0003-3560-291X
University of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, the freeze-drying of liposome dispersions is still necessary to provide a solid dosage form intended for different routes of administration (i.e., parenteral, oral, nasal and/or pulmonary). However, after decades of studies the optimization of process conditions remains still challenging since the freezing and the dehydration destabilize the vesicle organization with the concomitant drug leakage. Starting from the thermal properties of phospholipids, this work reviews the main formulation and process parameters which can guarantee a product with suitable characteristics and increase the efficiency of the manufacturing process. In particular, an overview of the cryo- and/or lyo-protective mechanisms of several excipients and the possible use of co-solvent mixtures is provided. Attention is also focused on the imaging methods recently proposed to characterize the appearance of freeze-dried products and liposome dispersions upon reconstitution. The combination of such data would allow a better knowledge of the factors causing inter-vials variability in the attempt to improve the quality of the final medicinal product.

Indexed as

cake appearancecryoprotectantfreeze-dryingfreezing rateliposomeslyoprotectantQbDsolventstabilitysublimationtime and temperature

Identifiers

PMID30154315
PMCPMC6161153
OpenAlexW2889300357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.